From transcription profile to expression: The signaling repertoire of the SK-N-MC neuroepithelioma cell-line

Journal of Receptors and Signal Transduction

Volumn 24, Issue 4, 2004, Pages 257-282

  Bader, Jürgen E ^a   Deckert, Cornelia M ^a   Koglin, Norman ^a   Pluder, Franka ^a   Mörl, Karin ^a   Koczan, Dirk ^b   Thiesen, Hans Jürgen ^b   Beck Sickinger, Annette G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Affymetrix GeneChip; Expression profile; Immunoblot; Proteome; Receptor binding experiments; RT PCR; SK N MC neuroepithelioma cell line; Transcription profile; Transcriptome; Translatome; Western blot

Indexed keywords

ANTIBODY; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; OREXIN RECEPTOR; PROTEIN SUBUNIT; PROTEOME; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STRAIN SK N MC; CONTROLLED STUDY; GENBANK; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MODEL; NEUROEPITHELIOMA; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA HYBRIDIZATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MEMBRANE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOBLOTTING; INHIBITORY CONCENTRATION 50; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PROTEIN BINDING; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RECEPTORS, NEUROPEPTIDE Y; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, COMPLEMENTARY; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 11144247915     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1081/RRS-200035220     Document Type: Article

References (53)

1. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973; 33:2643-2652.
2. Spengler BA, Biedler JL, Helson L, Freedman LS. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells established in vitro. In Vitro 1973; 8:410.
3. McKeon C, Thiele CJ, Ross RA, Kwan M, Triche TJ, Miser JS, Israel MA. Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Res 1988; 48:4307-4311.
4. Barnes EN, Biedler JL, Spengler BA, Lyser KM. The fine structure of continuous human neuroblastoma lines SK-N-SH, SK-N-BE(2), and SK-N-MC. In Vitro 1981; 17:619-631.
5. Dunn T, Praissman L, Hagag N, Viola MV. ERG gene is translocated in an Ewing's sarcoma cell line. Cancer Genet and Cytogenet 1994; 76:19-22.
6. Wai DH, Schaefer KL, Schramm A, Korsching E, Van Valen F, Ozaki T, Boecker W, Schweigerer L, Dockhorn-Dworniczak B, Poremba C. Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int J Oncol 2002; 20:441-451.
7. Edvinsson L, Aim R, Shaw D, Rutledge RZ, Koblan KS, Longmore J, Kane SA. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells. Eur J Pharmacol 2002; 434:49-53.
8. Razik MA, Lee K, Price RR, Williams MR, Ongjoco RR, Dole MK, Rudner XL, Kwatra MM, Schwinn DA. Transcriptional regulation of the human alpha1a-adrenergic receptor gene: characterization of the 5′-regulatory and promoter region. J Biol Chem 1997; 272:28237-28246.
9. Susulic VS, LaVallette L, Duzic E, Chen L, Shuey D, Karathanasis SK, Steiner KE. Expression of the human beta(3)-adrenergic receptor gene in SK-N-MC cells is under the control of a distal enhancer. Endocrinology 2001; 142:1935-1949.
10. Chaudhry A, Granneman JG. Influence of cell type upon the desensitization of the beta 3-adrenergic receptor. J Pharmacol Exp Ther 1994; 271:1253-1258.
11. Theroux TL, Esbenshade TA, Peavy RD, Minneman KP. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 1996; 50:1376-1387.
12. 2+ in SK-N-MC cells. Br J Pharmacol 1998; 125:1202-1211.
13. Fisher SK, Landon RE. Identification of multiple phosphoinositide-linked receptors on human SK-N-MC neuroepithelioma cells. J Neurochem 1991; 57:1599-1608.
14. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 1994; 91:4892-4896.
15. Sidhu A, Olde B, Humblot N, Kimura K, Gardner N. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells. Neuroscience 1999; 91:537-547.
16. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350:610-614.
17. Matsumoto M, Hidaka K, Tada S, Tasaki Y, Yamaguchi T. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J Neurochem 1996; 66:915-919.
18. Schaak S, Cayla C, Blaise R, Quinchon F, Paris H. HepG2 and SK-N-MC: two human models to study alpha-2 adrenergic receptors of the alpha-2C subtype. J Pharmacol Exp Ther 1997; 281:983-991.
19. Gordon EA, Kohout TA, Fishman PH. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line. J Neurochem 1990; 55:506-513.
20. Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlested C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem 1992; 267:10935-10938.
21. Wahlestedt C, Grundemar L, Hakanson R, Heilig M, Shen GH, Zukowska-Grojec Z, Reis DJ. Neuropeptide Y receptor subtypes, Y1 and Y2. Ann NY Acad Sci 1990; 611:7-26.
22. Schwartz TW, Fuhlendorff J, Kjems LL, Kristensen MS, Vervelde M, O'Hare M, Krstenansky JL, Bjornholm B. Signal epitopes in the three-dimensional structure of neuropeptide Y. Interaction with Y1, Y2, and pancreatic polypeptide receptors. Ann NY Acad Sci 1990; 611:35-47.
23. Wieland HA, Soll RM, Doods HN, Stenkamp D, Hurnaus R, Lammle B, Beck-Sickinger AG. The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor. Eur J Biochem 2002; 269:1128-1135.
24. Van Valen F, Piechot G, Jurgens H. Calcitonin gene-related peptide (CGRP) receptors are linked to cyclic adenosine monophosphate production in SK-N-MC human neuroblastoma cells. Neurosci Lett 1990; 119:195-198.
25. Daines RA, Sham KKC, Taggart JJ, Kingsbury WD, Chan J, Breen A, Disa J, Aiyar N. Quinine analogs as non-peptide calcitonin gene-related peptide (CGRP) receptor antagonists. Bioorg Med Chem Lett 1997; 7:2673-2676.
26. Edvinsson L, Sams A, Jansen-Olesen I, Tajti J, Kane SA, Rutledge RZ, Koblan KS, Hill RG, Longmore J. Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur J Pharmacol 2001; 415:39-44.
27. Mustafa T, Chai SY, Mendelsohn FA, Moeller I, Albiston AL. Characterization of the AT(4) receptor in a human neuroblastoma cell line (SK-N-MC). J Neurochem 2001; 76:1679-1687.
28. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FAO, Simpson RJ, Connolly LM, Chai SY. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 2001; 276:48623-48626.
29. Berger K, Winzell MS, Erlanson-Albertsson C. Binding of enterostatin to the human neuroepithelioma cell line SK-N-MC. Peptides 1998; 19:1525-1531.
30. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, Brown A, Rodriguez SS, Weller JR, Wright AC, Bergmann JE, Gaitanaris GA. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 2003; 100:4903-4908.
31. Hamm HE, Gilchrist A. Heterotrimeric G proteins. Curr Opin Cell Biol 1996; 8:189-196.
32. Hamm HE. The many faces of G protein signaling. J Biol Chem 1998; 273:669-672.
33. Sato M, Kataoka R, Dingus J, Wilcox M, Hildebrandt JD, Lanier SM. Factors determining specificity of signal transduction by G-protein-coupled receptors: regulation of signal transfer from receptor to G-protein. J Biol Chem 1995; 270:15269-15276.
34. Jordan JD, Landau EM, Iyengar R. Signaling networks: the origins of cellular multitasking. Cell 2000; 103:193-200.
35. Shou J, Soriano R, Hayward SW, Cunha GR, Williams PM, Gao WQ. Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci USA 2002; 99:2830-2835.
36. Mong JA, Krebs C, Pfaff DW. Perspective: micoarrays and differential display PCR-tools for studying transcript levels of genes in neuroendocrine systems. Endocrinology 2002; 143:2002-2006.
37. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003; 144:4562-4574.
38. Good E, Perschke S, Lopez R, Chang S, Kinsler A, Snowman A, Lacombe J, Fedock M, Zeppetello R, Zysk JR. Profiling established cell lines as a means to screening diversity. J Biomol Screen 1998; 3:231-236.
39. Orntoft TF, Thykjaer T, Waldman FM, Wolf H, Celis JE. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol Cell Proteomics 2002; 1:37-45.
40. Moser C, Bernhardt G, Michel J, Schwarz H, Buschauer A. Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells. Can J Physiol Pharmacol 2000; 78:134-142.
41. Bischoff A, Puttmann K, Kotting A, Moser C, Buschauer A, Michel MC. Limited signal transduction repertoire of human Y(5) neuropeptide Y receptors expressed in HEC-1B cells. Peptides 2001; 22:387-394.
42. Teague TK, Hildeman D, Kedl RM, Mitchell T, Rees W, Schaefer BC, Bender J, Kappler J, Marrack P. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc Natl Acad Sci USA 1999; 96:12691-12696.
43. Cabrele C, Wieland HA, Koglin N, Stidsen C, Beck-Sickinger AG. Ala31-Aib32: identification of the key motif for high affinity and selectivity of neuropeptide Y at the Y5-receptor. Biochemistry 2002; 41:8043-8049.
44. Koglin N, Lang M, Rennert R, Beck-Sickinger AG. Facile and selective nanoscale labeling of peptides in solution by using photolabile protecting groups. J Med Chem 2003; 46:4369-4372.
45. Soll RM, Dinger MC, Lundell I, Larhammer D, Beck-Sickinger AG. Novel analogues of neuropeptide Y with a preference for the Y1-receptor. Eur J Biochem 2001; 268:2828-2837.
46. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
47. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393:333-339.
48. Li L, Mayer M, Schneider E, Schreiber E, Bernhardt G, Peng S, Buschauer A. Preparation of fluorescent nonpeptidic neuropeptide Y receptor ligands: analogues of the quinazoline-type anti-obesity Y5 antagonist CGP 71683A. Arch Pharm (Weinheim) 2003; 336:585-590.
49. Galiano S, Erviti O, Perez S, Moreno A, Juanenea L. Aldana I, Monge A. Synthesis of new thiophene and benzo[b]thiophene hydrazide derivatives as human NPY Y(5) antagonists. Bioorg Med Chem Lett 2004; 14:597-599.
50. Price DT, Chari RS, Berkowitz DE, Meyers WC, Schwinn DA. Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification. Mol Pharmacol 1994; 46:221-226.
51. Bahouth SW, Sowinski KM, Lima JJ. Regulation of human beta(1)-adrenergic receptors and their mRNA in neuroepithelioma SK-N-MC cells: effects of agonist, forskolin, and protein kinase A. Biochem Pharmacol 2001; 62:1211-1220.
52. Hegde PS, White IR, Debouck C. Interplay of transcriptomics and proteomics. Curr Opin Biotechnol 2003; 14:647-651.
53. Eggenberger M, Fluhmann B, Muff R, Lauber M, Lichtensteiger W, Hunziker W, Fischer JA, Born W. Structure of a parathyroid hormone/parathyroid hormone-related peptide receptor of the human cerebellum and functional expression in human neuroblastoma SK-N-MC cells. Brain Res Mol Brain Res 1996; 36:127-136.